Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp shows a slight decrease today, losing -€0.040 (-0.990%) compared to yesterday.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -0.990% | -0.498% | 8.108% | -41.176% | -27.273% | 238.983% | -45.946% |
| Intellia Therapeutics Inc | 8.260% | -15.588% | 12.826% | 46.841% | 47.066% | -66.492% | -82.006% |
| Cardio3 Biosciences S.A. | 0.360% | 0.722% | -0.357% | -35.116% | 106.667% | -55.573% | -94.936% |
| Polynovo Ltd | 0.000% | -0.870% | 12.871% | -10.938% | -16.176% | -40.625% | -69.681% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat